Novo Nordisk and Hims & Hers strike deal in weight loss drug market

Name: Novo Nordisk and Hims & Hers strike deal in weight loss drug market
Uploaded: 2026-03-09T19:53:14Z
Duration: 52 s
Description: Liz Claman details a surprising turn in the weight loss drug market. Novo Nordisk has agreed to drop its patent infringement lawsuit against Hims & Hers and will now sell its Wegovy and Ozempic drugs through Hims & Hers' telehealth platform. This agreement has caused shares of Hims & Hers to soar by over 42%, while Novo Nordisk also sees a slight increase.

The Claman Countdown · FBN · Mar 9, 2026 · 52sSign Up Now

Already a subscriber?

Liz Claman details a surprising turn in the weight loss drug market. Novo Nordisk has agreed to drop its patent infringement lawsuit against Hims & Hers and will now sell its Wegovy and Ozempic drugs through Hims & Hers' telehealth platform. This agreement has caused shares of Hims & Hers to soar by over 42%, while Novo Nordisk also sees a slight increase.